Sur notre site Internet, nous utilisons des cookies (témoins) pour nous aider à vous offrir la meilleure expérience en ligne possible. Si vous poursuivez et acceptez tous les cookies, vous recevrez tous ceux que nous utilisons sur le site. Si vous souhaitez définir quels sont les cookies que vous recevez, vous pouvez modifier ces paramètres à tout moment en cliquant sur les liens fournis en bas de chaque page du site. Découvrez comment nous utilisons les cookies et comment vous pouvez modifier vos paramètres.
One of the hottest topics in the biopharmaceutical industry today is "continuous bioprocessing". Buzzwords such as "process intensification", "next generation bioprocessing", "process optimization", and "integrated, connected manufacturing" are prevalent.
This is no surprise considering that by 2025, it is expected that 20 percent of revenue from molecules that are still in the pipeline today will come from drugs manufactured with next generation technologies. It is estimated that roughly 35 percent of today’s commercial molecules will utilize process intensification methods within the next 5 — 10 years.
But what actually is next generation bioprocessing? How are industry players defining it and how will they pursue and successfully implement this approach? And is continuous processing always the ultimate end goal drug manufacturers around the globe are, or should be, striving for?
Discover exciting answers below!
What is Next Generation Bioprocessing? A video realized with The American Pharmaceutical Review
Watch our leaders addressing how next generation processing will have a significant impact on how therapies are brought to market, delivering them to patients faster and more cost-effectively than ever before.
Welcome to the Next Generation of Bioprocessing An eBook published with The Medicine Maker
Experts from both biologics manufacturers and from Merck provide their insights and perspectives on the on-going paradigm shift towards next generation bioprocessing occurring in today’s and tomorrow’s biopharma landscape.
In this webinar series, three subject matter experts will share their perspective on the future of the industry and provide specific case examples that demonstrate how collaboration enables trends that are shaping the future pharmaceutical manufacturing landscape.